Ibio Inc (IBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBIO | AMGN | VRTX | REGN | BMY |
| Company | Ibio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 2.0300 | 311.00 | 403.50 | 926.94 | 44.08 |
| High | 2.1500 | 311.00 | 403.50 | 958.13 | 44.08 |
| Low | 1.9500 | 311.00 | 403.50 | 926.94 | 44.08 |
| Last | 1.9900 | 311.00 | 403.50 | 957.00 | 44.08 |
| Change | -0.0400 | -0.29 | +2.42 | +19.39 | +0.09 |
| % Change | -1.97% | -0.09% | +0.60% | +2.07% | +0.20% |
| Volume | 174,300 | 4,172 | 1,379 | 547,300 | 12,144 |
| 20-Day Average Volume | 326,005 | 2,555,554 | 985,074 | 518,580 | 13,852,087 |
| Previous Close | 2.0300 | 311.29 | 401.08 | 937.61 | 43.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9010 | 274.36 | 398.39 | 909.87 | 47.11 |
| 20-Day Raw Stochastic | 41.18% | 81.27% | 78.36% | 98.64% | 8.95% |
| 20-Day Relative Strength | 52.99% | 71.84% | 49.21% | 59.08% | 29.82% |
| Weighted Alpha | -85.75 | +34.54 | +15.30 | +26.69 | -36.02 |
| Today's Opinion | 8% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 8% Buy | 24% Buy | 8% Buy | 48% Buy | 100% Sell |
| Last Month's Opinion | 24% Sell | 8% Sell | 40% Buy | 56% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.07% since 04/26/24 | +12.53% since 04/29/24 | +1.84% since 04/29/24 | +8.36% since 04/26/24 | -1.25% since 04/29/24 |
| Low | 1.6400 on 04/29/24 | 272.35 on 04/30/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 43.33 on 05/02/24 |
| High | 2.1800 on 05/02/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 958.13 on 05/03/24 | 44.76 on 04/30/24 |
| 1-Month | |||||
| %Chg | -32.31% since 04/03/24 | +15.21% since 04/05/24 | -0.78% since 04/05/24 | +0.64% since 04/03/24 | -14.11% since 04/05/24 |
| Low | 1.6400 on 04/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.9400 on 04/04/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 962.20 on 04/04/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +80.93% since 02/02/24 | -1.60% since 02/06/24 | -3.04% since 02/06/24 | +1.25% since 02/02/24 | -10.52% since 02/06/24 |
| Low | 1.0500 on 03/20/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 4.9800 on 03/28/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -65.12% since 11/03/23 | +13.99% since 11/06/23 | +4.60% since 11/06/23 | +17.15% since 11/03/23 | -16.50% since 11/06/23 |
| Low | 1.0214 on 01/18/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 6.4680 on 11/06/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,934 | 166,968,480 | 103,662,736 | 105,042,232 | 89,172,128 |
| Shares Outstanding, K | 3,484 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -65,010,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 50,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -5,750,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | -3.22 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.42 on 02/09/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 25.27 | 41.62 |